Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: A prospective study

Stroke

Volumn 41, Issue 1, 2010, Pages 173-176

  Kim, Suk Jae ^a   Heo, Kwang Gi ^a,b   Shin, Hee Young ^a   Bang, Oh Young ^a   Kim, Gyeong Moon ^a   Chung, Chin Sang ^a   Kim, Keon Ha ^a   Jeon, Pyoung ^a   Kim, Jong Soo ^a   Hong, Seung Chyul ^a   Lee, Kwang Ho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Rodem Clinic   (South Korea)

Author keywords

Autoantibodies; Moyamoya disease; Thyroid gland

Indexed keywords

THYROID ANTIBODY;

ANGIOGRAPHY; ARTICLE; AUTOIMMUNITY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHILD; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID HORMONES; YOUNG ADULT;

EID: 74049114125     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.562264     Document Type: Article

References (12)

1. Sasaki T, Nogawa S, Amano T. Co-morbidity of moyamoya disease with Graves' disease. Report of three cases and a review of the literature. Intern Med. 2006;45:649-653.
2. Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, Ramsby GR. Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid. 1997;7:625-629.
3. Utku U, Asil T, Celik Y, Tucer D. Reversible MR angiographic findings in a patient with autoimmune graves disease. AJNR Am J Neuroradiol. 2004;25:1541-1543.
4. Suzuki J, Kodama M, Fujisawa S. A Study About the Cause of Moyamoya Disease. The 1980 Annual Report of the Research Committee on the Idiopathic Occlusive Disease of Circle of Willis. Tokyo: Japanese Ministry of Health and Welfare; 1981:21-34.
5. van Diemen-Steenvoorde R, van Nieuwenhuizen O, de Klerk JB, Duran M. Quasi-moyamoya disease and heterozygosity for homocystinuria in a five-year-old girl. Neuropediatrics. 1990;21:110-112.
6. Colleran KM, Ratliff DM, Burge MR. Potential association of thyrotox-icosis with vitamin B and folate deficiencies, resulting in risk for hyper-homocysteinemia and subsequent thromboembolic events. Endocr Pract. 2003;9:290-295.
7. Lee TH, Hsu WC, Chen CJ, Chen ST. Etiologic study of young ischemic stroke in Taiwan. Stroke. 2002;33:1950-1955.
8. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke. 1998;29:1347-1351.
9. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT III, Zipfel GJ, Dacey RG Jr, Derdeyn CP. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490-1496.
10. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39:3193-3200.
11. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, Tsuji I, Inaba Y, Yoshimoto T. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39:42-47.
12. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056-1066.